B-cell and T-cell activation in South African HIV-1-positive non-Hodgkin’s lymphoma patients

Southern African Journal of HIV Medicine

 
 
Field Value
 
Title B-cell and T-cell activation in South African HIV-1-positive non-Hodgkin’s lymphoma patients
 
Creator Flepisi, Brian T. Bouic, Patrick Sissolak, Gerhard Rosenkranz, Bernd
 
Subject health sciences; biomedical sciences; oncology HIV-1 infection; non-Hodgkin’s lymphoma; B-cell activation; T-cell activation
Description Background: Altered immune mechanisms play a critical role in the pathogenesis of non-Hodgkin’s lymphoma (NHL). HIV-1 (HIV) infection is associated with a state of excessive T-cell activation, which can lead to increased T-cell turnover and lymph node fibrosis.Objectives: This study aimed to determine the serum levels of circulating B-cell activation markers, and the expression of T-cell activation and regulatory markers in HIV-positive NHL patients.Method: The serum levels of circulating soluble(s) sCD20, sCD23, sCD27, sCD30 and sCD44 molecules, all of which are biomarkers of B-cell activation, were determined by enzyme-linked immunosorbent assays (ELISA), while biomarkers of T-cell activation (CD8+CD38+) and regulation (FoxP3) were determined by flow cytometry in 141 subjects who were divided into five groups: Combination antiretroviral therapy (ART)-naïve HIV-positive patients; ART-treated HIV-positive patients; HIV-negative NHL patients; HIV-positive NHL patients on ART; and healthy controls.Results: HIV-positive NHL patients had significantly higher serum levels of sCD20, sCD23, sCD30 and sCD44 than HIV-negative NHL patients, while all five biomarkers were significantly elevated in HIV-positive NHL patients when compared with ART-treated HIV-positive patients. HIV-positive NHL patients had higher CD8+CD38+ and lower FoxP3 expression than HIV-negative NHL and ART-treated HIV-positive patients.Conclusion: B-cell activation is increased in HIV-positive NHL patients and is associated with reduced regulatory T-cell populations and increased CD8+ T-cell activation.
 
Publisher AOSIS
 
Contributor National Research Foundation
Date 2018-11-07
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Observational case-control
Format text/html application/epub+zip application/xml application/pdf
Identifier 10.4102/sajhivmed.v19i1.809
 
Source Southern African Journal of HIV Medicine; Vol 19, No 1 (2018); 7 pages 2078-6751 1608-9693
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajhivmed.org.za/index.php/hivmed/article/view/809/1294 https://sajhivmed.org.za/index.php/hivmed/article/view/809/1293 https://sajhivmed.org.za/index.php/hivmed/article/view/809/1295 https://sajhivmed.org.za/index.php/hivmed/article/view/809/1292
 
Coverage Cape Town; South Africa — 18 and above; males; females; black; whites; coloreds
Rights Copyright (c) 2018 Brian T. Flepisi, Patrick Bouic, Gerhard Sissolak, Bernd Rosenkranz https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT